4.8 Review

How autophagy controls the intestinal epithelial barrier

Journal

AUTOPHAGY
Volume 18, Issue 1, Pages 86-103

Publisher

TAYLOR & FRANCIS INC
DOI: 10.1080/15548627.2021.1909406

Keywords

Autophagy; Crohn disease; IBD; intestinal epithelium; intestinal stem cells; MTOR

Categories

Funding

  1. Canadian Institutes of Health Research [FDN-14333]
  2. Natural Sciences and Engineering Council [RGPIN-201]

Ask authors/readers for more resources

Autophagy is a crucial cellular process for recycling organelles and protein aggregates, as well as destroying intracellular pathogens. It plays a key role in the maintenance and repair of intestinal epithelium, supporting intestinal barrier function and influencing the development of intestinal disease.
Macroautophagy/autophagy is a cellular catabolic process that results in lysosome-mediated recycling of organelles and protein aggregates, as well as the destruction of intracellular pathogens. Its role in the maintenance of the intestinal epithelium is of particular interest, as several autophagy-related genes have been associated with intestinal disease. Autophagy and its regulatory mechanisms are involved in both homeostasis and repair of the intestine, supporting intestinal barrier function in response to cellular stress through tight junction regulation and protection from cell death. Furthermore, a clear role has emerged for autophagy not only in secretory cells but also in intestinal stem cells, where it affects their metabolism, as well as their proliferative and regenerative capacity. Here, we review the physiological role of autophagy in the context of intestinal epithelial maintenance and how genetic mutations affecting autophagy contribute to the development of intestinal disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cell Biology

NLRX1 Acts as an Epithelial-Intrinsic Tumor Suppressor through the Modulation of TNF-Mediated Proliferation

Ivan Tattoli, Samuel A. Killackey, Elisabeth G. Foerster, Raphael Molinaro, Charles Maisonneuve, Muhammed A. Rahman, Shawn Winer, Daniel A. Winer, Catherine J. Streutker, Dana J. Philpott, Stephen E. Girardin

CELL REPORTS (2016)

Article Microbiology

Complement C3 Drives Autophagy-Dependent Restriction of Cyto-invasive Bacteria

Matthew T. Sorbara, Elisabeth G. Foerster, Jessica Tsalikis, Mena Abdel-Nour, Joseph Mangiapane, Imogen Sirluck-Schroeder, Ivan Tattoli, Rob van Dalen, David E. Isenman, John R. Rohde, Stephen E. Girardin, Dana J. Philpott

CELL HOST & MICROBE (2018)

Review Biochemistry & Molecular Biology

NOD1 and NOD2 in inflammation, immunity and disease

Tapas Mukherjee, Elise Sofie Hovingh, Elisabeth G. Foerster, Mena Abdel-Nour, Dana J. Philpott, Stephen E. Girardin

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2019)

Editorial Material Microbiology

Carving a Niche for Antibacterial α-Defensins when Craving

Elisabeth G. Foerster, Stephen E. Girardin

CELL HOST & MICROBE (2019)

Article Cell Biology

Nod1 promotes colorectal carcinogenesis by regulating the immunosuppressive functions of tumor-infiltrating myeloid cells

Charles Maisonneuve, Derek K. L. Tsang, Elisabeth G. Foerster, Lukian Maxence Robert, Tapas Mukherjee, Dave Prescott, Ivan Tattoli, Paul Lemire, Daniel A. Winer, Shawn Winer, Catherine J. Streutker, Kaoru Geddes, Ken Cadwell, Richard L. Ferrero, Alberto Martin, Stephen E. Girardin, Dana J. Philpott

Summary: The pioneering studies in the early 1980s indicated that bacterial peptidoglycan-derived muramyl peptides (MPs) have dual functions of either stimulation or immunosuppression depending on the chronicity of exposure. This study demonstrates the immunosuppressive potential of Nod1, the bacterial sensor of diaminopimelic acid (DAP)-containing MPs, in reprogramming macrophages and inducing myeloid-derived suppressor cells (MDSCs) to maintain their immunosuppressive activity, ultimately promoting tumor progression in colorectal cancer.

CELL REPORTS (2021)

Article Immunology

Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunity

Kebria Hezaveh, Rahul S. Shinde, Andreas Kloetgen, Marie Jo Halaby, Sara Lamorte, M. Teresa Ciudad, Rene Quevedo, Luke Neufeld, Zhe Qi Liu, Robbie Jin, Barbara T. Grunwald, Elisabeth G. Foerster, Danica Chaharlangi, Mengdi Guo, Priya Makhijani, Xin Zhang, Trevor J. Pugh, Devanand M. Pinto, Ileana L. Co, Alison P. McGuigan, Gun Ho Jang, Rama Khokha, Pamela S. Ohashi, Grainne M. O'Kane, Steven Gallinger, William W. Navarre, Heather Maughan, Dana J. Philpott, David G. Brooks, Tracy L. McGaha

Summary: The study demonstrates the critical role of AhR in the function of tumor-associated macrophages (TAMs) in PDAC, showing that deletion of Ahr reduces PDAC growth, increases the frequency of IFN CD8(+) T cells, and dietary tryptophan metabolism affects AhR activity through the conversion of tryptophan to indoles by Lactobacillus. High AHR expression in PDAC patients is associated with disease progression, mortality, and an immune-suppressive TAM phenotype, indicating a conserved regulatory axis in human disease.

IMMUNITY (2022)

Article Gastroenterology & Hepatology

A single cell survey of the microbial impacts on the mouse small intestinal epithelium

Derek K. L. Tsang, Ryan J. Wang, Oliver De Sa, Arshad Ayyaz, Elisabeth G. Foerster, Giuliano Bayer, Shawn Goyal, Daniel Trcka, Bibaswan Ghoshal, Jeffrey L. Wrana, Stephen E. Girardin, Dana J. Philpott

Summary: This study used single-cell RNA sequencing to investigate the crosstalk between microbes and intestinal epithelial cells. The presence of microbiota did not significantly alter the overall cellular composition of the epithelium, but did induce changes in specific cell types and gene expression profiles. The findings suggest that microbe-derived metabolites directly activate and regulate mTOR signaling. Overall, this research provides valuable insights into the impact of the microbiota on the small intestinal epithelium.

GUT MICROBES (2022)

Article Immunology

ATG16L1 protects from interferon-γ-induced cell death in the small intestinal crypt

Elisabeth G. Foerster, Derek K. L. Tsang, Shawn Goyal, Susan J. Robertson, Lukian M. Robert, Heather Maughan, Catherine J. Streutker, Stephen E. Girardin, Dana J. Philpott

Summary: The breakdown of the intestinal mucosal barrier is a key factor in the progression to Crohn disease (CD), and various risk factors, such as a genetic polymorphism of the autophagy gene ATG16L1, contribute to this process. The researchers investigated the role of Atg16l1 in protecting the small intestinal epithelium and found that its deficiency led to increased intestinal damage, inflammation, and reduced survival in mice. The study suggests that targeting interferon-gamma (IFN-gamma) may be a potential therapeutic approach for CD patients with ATG16L1 variants.

MUCOSAL IMMUNOLOGY (2023)

No Data Available